The Diagnosis and Treatment of Fungal Endophthalmitis: An Update
暂无分享,去创建一个
[1] M. Soleimani,et al. Early and complete vitrectomy versus tap and inject in acute post cataract surgery endophthalmitis presenting with hand motion vision; a quasi-experimental study , 2022, BMC Ophthalmology.
[2] A. Pathengay,et al. Sight-threatening intraocular infection in patients with COVID-19 in India , 2021, Indian journal of ophthalmology.
[3] Chinmay P. Nakhwa. Endogenous fungal endopthalmitis treated with intravitreal caspofungin in a COVID-19 recovered patient: A case report , 2021, Indian journal of ophthalmology.
[4] Abdelrahman M. Elhusseiny,et al. Fungal Endophthalmitis: A Comprehensive Review , 2021, Journal of fungi.
[5] Kaili Wu,et al. Comparison of causative microorganisms of posttraumatic endophthalmitis with and without retained intraocular foreign bodies , 2021, BMC Ophthalmology.
[6] S. Chee,et al. Candida Endophthalmitis Treated Successfully With Isavuconazole: A Case Report , 2021, Open forum infectious diseases.
[7] T. Das,et al. Fungal endophthalmitis: Analysis of 730 consecutive eyes from seven tertiary eye care centers in India. , 2021, Ophthalmology. Retina.
[8] Aisi Fu,et al. Microbiological diagnosis of endophthalmitis using nanopore targeted sequencing , 2021, Clinical & experimental ophthalmology.
[9] J. B. Bond,et al. American Academy of Ophthalmology recommendations on screening for endogenous Candida endophthalmitis. , 2021, Ophthalmology.
[10] P. White,et al. Molecular Diagnosis of Yeast Infections , 2021, Current Fungal Infection Reports.
[11] Daraius Shroff,et al. Endogenous fungal endophthalmitis following intensive corticosteroid therapy in severe COVID-19 disease , 2021, Indian journal of ophthalmology.
[12] P. Majumder,et al. A case series of presumed fungal endogenous endophthalmitis in post COVID-19 patients , 2021, Indian journal of ophthalmology.
[13] Kazuaki Matsumoto,et al. Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis , 2021, Journal of fungi.
[14] T. Lupia,et al. Exogenous Fungal Endophthalmitis: Clues to Aspergillus Aetiology with a Pharmacological Perspective , 2020, Microorganisms.
[15] L. Ostrosky-Zeichner,et al. Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance , 2020, Journal of fungi.
[16] Tapan P. Patel,et al. Antimicrobial guide to posterior segment infections , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.
[17] T. Mir,et al. Incidence of Drug Use-Related Endogenous Endophthalmitis Hospitalizations in the United States, 2003 to 2016. , 2020, JAMA ophthalmology.
[18] Ting Zhang,et al. Vitrectomy combined with intravitreal antifungal therapy for posttraumatic fungal endophthalmitis in eastern China , 2020, BMC Ophthalmology.
[19] S. Ormanns,et al. Comparison of β-D-Glucan and Galactomannan in Serum for Detection of Invasive Aspergillosis: Retrospective Analysis with Focus on Early Diagnosis , 2020, Journal of fungi.
[20] Nicoleta Anton,et al. Endogenous Endophthalmitis: A Review of Case Series Published between 2011 and 2020 , 2020, Journal of ophthalmology.
[21] Ruben Lim Bon Siong,et al. Infectious endophthalmitis at a Philippine tertiary hospital: a ten-year retrospective study , 2020, Journal of Ophthalmic Inflammation and Infection.
[22] H. Flynn,et al. The Role of Systemic Antimicrobials in the Treatment of Endophthalmitis: A Review and an International Perspective , 2020, Ophthalmology and Therapy.
[23] O. Kurzai,et al. Case Report: Beyond the Blood-retina Barrier: Intravitreal Caspofungin for Fungal Endophthalmitis. , 2020, Optometry and vision science : official publication of the American Academy of Optometry.
[24] F. Kuhn,et al. Complete and Early Vitrectomy for Endophthalmitis After Cataract Surgery: An Alternative Treatment Paradigm , 2020, Clinical ophthalmology.
[25] G. Ying,et al. CLINICAL UTILITY OF BETA-D-GLUCAN TESTING FOR ENDOGENOUS FUNGAL CHORIORETINITIS OR ENDOPHTHALMITIS. , 2020, Retina.
[26] T. Mir,et al. Trends in Infantile Endogenous Endophthalmitis Hospitalizations in the United States: An Analysis from 2007-2014 using the National Inpatient Sample. , 2020, Ophthalmology. Retina.
[27] F. Persat,et al. Aspergillus endophthalmitis: Potential role for vitreous galactomannan testing? , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[28] Gopal S. Pillai,et al. Clinical profile and outcome of endogenous endophthalmitis at a quaternary referral centre in South India , 2020, Indian journal of ophthalmology.
[29] A. Pathengay,et al. Clinical presentations, microbiology and management outcomes of culture-proven endogenous endophthalmitis in India , 2020, Indian journal of ophthalmology.
[30] K. Ramasamy,et al. Post-cataract Surgery Fungal Endophthalmitis: Management Outcomes and Prognostic Factors , 2020, Ocular immunology and inflammation.
[31] Xiaofeng Hu,et al. Utility of Intraocular Fluid β-D-glucan Testing in Fungal Endophthalmitis: A Series of 5 Cases , 2020, The American journal of case reports.
[32] Nila S. Radhakrishnan,et al. Endogenous Endophthalmitis: yield of the diagnostic evaluation , 2020, BMC Ophthalmology.
[33] A. Pathengay,et al. Aspergillus Endophthalmitis: Clinical Presentations and Factors Determining Outcomes. , 2020, Asia-Pacific journal of ophthalmology.
[34] B. Seitz,et al. Recurrent fungal endophthalmitis after intravitreal injections of bevacizumab , 2020, American journal of ophthalmology case reports.
[35] Mengjie Liu,et al. Endophthalmitis associated with fungal keratitis and penetrating injuries in North China , 2020, European journal of ophthalmology.
[36] L. Spadea,et al. Diagnostic and Management Strategies of Aspergillus Endophthalmitis: Current Insights , 2019, Clinical ophthalmology.
[37] Savitri Sharma,et al. Targeted High-Throughput Sequencing Identifies Predominantly Fungal Pathogens in Patients with Clinically Infectious, Culture-Negative Endophthalmitis in South India , 2019, Microorganisms.
[38] P. Singh,et al. Pathobiology of Aspergillus Fumigatus Endophthalmitis in Immunocompetent and Immunocompromised Mice , 2019, Microorganisms.
[39] L. Gopal,et al. Endogenous endophthalmitis in children and adolescents: Case series and literature review , 2019, Indian journal of ophthalmology.
[40] Jun Cheng,et al. RISK FACTORS, TREATMENT STRATEGIES, AND OUTCOMES OF ENDOPHTHALMITIS ASSOCIATED WITH SEVERE FUNGAL KERATITIS. , 2019, Retina.
[41] H. Ikeuchi,et al. The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia , 2019, PloS one.
[42] A. Pathengay,et al. Infectious endophthalmitis leading to evisceration: spectrum of bacterial and fungal pathogens and antibacterial susceptibility profile , 2019, Journal of Ophthalmic Inflammation and Infection.
[43] T. Walsh,et al. Fungal Endophthalmitis after Intravitreal Injections of Triamcinolone Contaminated by a Compounding Pharmacy: Five-Year Follow-up of 23 Patients. , 2019, Ophthalmology. Retina.
[44] Savitri Sharma,et al. New insights into culture negative endophthalmitis by unbiased next generation sequencing , 2019, Scientific Reports.
[45] H. Kaplan,et al. Diagnostic Utility of Quantitative Polymerase Chain Reaction versus Culture in Endophthalmitis and Uveitis , 2019, Ocular immunology and inflammation.
[46] P. Singh,et al. Isavuconazole for Treatment of Experimental Fungal Endophthalmitis Caused by Aspergillus fumigatus , 2018, Antimicrobial Agents and Chemotherapy.
[47] A. Grzybowski,et al. The treatment of postoperative endophthalmitis: should we still follow the endophthalmitis vitrectomy study more than two decades after its publication? , 2018, Acta ophthalmologica.
[48] Andrea D. Tyler,et al. Evaluation of Oxford Nanopore’s MinION Sequencing Device for Microbial Whole Genome Sequencing Applications , 2018, Scientific Reports.
[49] F. Otero-Espinar,et al. Review of Intraocular Pharmacokinetics of Anti-Infectives Commonly Used in the Treatment of Infectious Endophthalmitis , 2018, Pharmaceutics.
[50] Cecilia S Lee,et al. A Review of the Role of Intravitreal Corticosteroids as an Adjuvant to Antibiotics in Infectious Endophthalmitis , 2018, Ocular immunology and inflammation.
[51] L. López-Soria,et al. Endophthalmitis caused by Fusarium: An emerging problem in patients with corneal trauma. A case series. , 2018, Revista iberoamericana de micologia.
[52] N. Davies,et al. A British Ophthalmological Surveillance Unit Study on metastatic endogenous endophthalmitis , 2018, Eye.
[53] M. Cavo,et al. Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia , 2018, Mycoses.
[54] Sukhum Silpa-archa,et al. Culture-Positive Endogenous Endophthalmitis: An Eleven-Year Retrospective Study in the Central Region of Thailand , 2017, Ocular immunology and inflammation.
[55] T. Das,et al. ROLE OF EARLY VITRECTOMY IN THE TREATMENT OF FUNGAL ENDOPHTHALMITIS , 2017, Retina.
[56] Joan W. Miller,et al. Endogenous Endophthalmitis in the American and Korean Population: An 8-year Retrospective Study , 2015, Ocular immunology and inflammation.
[57] K. Maruyama,et al. Endogenous Fusarium Endophthalmitis During Treatment for Acute Myeloid Leukemia, Successfully Treated with 25-Gauge Vitrectomy and Antifungal Medications , 2018, Mycopathologia.
[58] J. Buer,et al. Diagnostic performance of blood culture bottles for vitreous culture compared to conventional microbiological cultures in patients with suspected endophthalmitis , 2018, European Journal of Clinical Microbiology & Infectious Diseases.
[59] D. Marriott,et al. Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance. , 2017, Journal of visualized experiments : JoVE.
[60] A. M. Garrido-Hermosilla,et al. Extreme Surgical Maneuvers in Fungal Endophthalmitis , 2017, Ophthalmologica.
[61] J. Losa,et al. Is routine ophthalmoscopy really necessary in candidemic patients? , 2017, PloS one.
[62] P. White,et al. Diagnostic accuracy of fungal PCR and β-d-glucan for detection of candidaemia: a preliminary evaluation , 2017, Journal of Clinical Pathology.
[63] Ya-Chung Tian,et al. Epidemiology and outcomes of Endophthalmitis in chronic dialysis patients: a 13-year experience in a tertiary referral center in Taiwan , 2017, BMC Nephrology.
[64] Nicoleta Anton,et al. The Importance of Fluconazole in Treatment of Endogenous Endophtalmitis in Patients Prior Treated Using Negative Pressure Therapy for Wound Closure Contaminated with Meticillin-resistant Staphylococcus aureus , 2017 .
[65] D. Perlin,et al. Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification , 2017, The Journal of infectious diseases.
[66] Xiaofeng Lin,et al. Clinical Features and Visual Acuity Outcomes in Culture-Positive Endogenous Fungal Endophthalmitis in Southern China , 2017, Journal of ophthalmology.
[67] M. la Cour,et al. 59 eyes with endogenous endophthalmitis– causes, outcomes and mortality in a Danish population between 2000 and 2016 , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.
[68] M. Castanheira,et al. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans , 2017, Antimicrobial Agents and Chemotherapy.
[69] J. Duker,et al. An Outbreak of Endogenous Fungal Endophthalmitis Among Intravenous Drug Abusers in New England , 2017, JAMA ophthalmology.
[70] Boben Thomas,et al. Management of a case of Candida albicans endogenous endophthalmitis with intravitreal caspofungin , 2017, Indian Journal of Ophthalmology.
[71] D. Chiselita,et al. Successful treatment of fungal endophthalmitis using intravitreal caspofungin. , 2017, Arquivos Brasileiros de Oftalmologia.
[72] Avni P. Finn,et al. Intravenous Drug Use-Associated Endophthalmitis. , 2017, Ophthalmology. Retina.
[73] H. Flynn,et al. Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis , 2017, Retina.
[74] N. Nayak,et al. Clinicomicrobiological profile of endophthalmitis: A 10 year experience in a Tertiary Care Center in North India , 2017, Indian journal of pathology & microbiology.
[75] K. Bartz-Schmidt,et al. Outcomes of Primary Transconjunctival 23-Gauge Vitrectomy in the Diagnosis and Treatment of Presumed Endogenous Fungal Endophthalmitis , 2017, Ocular immunology and inflammation.
[76] D. Denning,et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[77] N. Curtis,et al. Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre. , 2016, The Journal of antimicrobial chemotherapy.
[78] J. Sobel,et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[79] H. Flynn,et al. Endophthalmitis: state of the art , 2015, Clinical ophthalmology.
[80] Bingqian Liu,et al. Causative organisms of post-traumatic endophthalmitis: a 20-year retrospective study , 2014, BMC Ophthalmology.
[81] A. Chakrabarti,et al. Management of recurrent postoperative fungal endophthalmitis , 2014, Indian journal of ophthalmology.
[82] Ajay E. Kuriyan,et al. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections , 2013, Journal of Ophthalmic Inflammation and Infection.
[83] H. Flynn,et al. Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. , 2013, American journal of ophthalmology.
[84] A. Friedman,et al. An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone. , 2013, JAMA ophthalmology.
[85] P. McCluskey,et al. FACTORS DETERMINING VISUAL OUTCOME IN ENDOGENOUS CANDIDA ENDOPHTHALMITIS , 2012, Retina.
[86] P. Sowmya,et al. Diagnostic Utility of Polymerase Chain Reaction on Intraocular Specimens to Establish the Etiology of Infectious Endophthalmitis , 2009, European journal of ophthalmology.
[87] B. Tarai,et al. FUNGAL ENDOPHTHALMITIS: Fourteen Years’ Experience From a Center in India , 2008, Retina.
[88] N. Rao,et al. A comparative clinicopathologic study of endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared to aspergillosis. , 2000, Transactions of the American Ophthalmological Society.
[89] T. Das,et al. Role of intravitreal dexamethasone in exogenous fungal endophthalmitis , 1999, Eye.
[90] C E Letocha,et al. The American Academy of Ophthalmology. , 1996, Archives of ophthalmology.
[91] L. Ficker,et al. Infectious endophthalmitis. , 1986, Transactions of the ophthalmological societies of the United Kingdom.